Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions

Molecular Vision

Volumn 19, Issue , 2013, Pages 796-803

  Zhang, Qiuhua ^a   Jiang, Youde ^a   Toutounchian, Jordan J ^a   Soderland, Carl ^b   Ryan Yates, C ^a   Steinle, Jena J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Cell Systems Corp ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; PLASMID DNA; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL SPECIFICITY; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MONOCYTE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS;

CELL ADHESION; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; RETINA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84876205588     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005; 438:960-6. [PMID: 16355161].
2. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Retinopathy in diabetes. Diabetes Care 2004; 27:Suppl 1S84-7. [PMID: 14693935].
3. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94:3171-82. [PMID: 19509100].
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821-30. [PMID: 14679177].
5. Miller C, Bartges J, Cornelius L, Norton N, Barton M. Tumor necrosis factor-alpha levels in adipose tissue of lean and obese cats. J Nutr 1998; 128:2751S-2S. [PMID: 9868256].
6. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14:561-6. [PMID: 14624132].
7. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. FASEB 2004; 18:1450-2.
8. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91. [PMID: 7678183].
9. Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, Krohne TU, Poulaki V, Semkova I. Kociok N TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009; 15:1418-28. [PMID: 19641635].
10. Jiang Y, Zhang Q, Soderland C, Steinle JJ. TNFalpha and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis. Cell Signal 2012; 24:1086-92. [PMID: 22266116].
11. Panjala SR, Jiang Y, Kern TS, Thomas SA, Steinle JJ. Increased tumor necrosis factor-alpha, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the beta-adrenergic receptor knockout mouse. Mol Vis 2011; 17:1822-8. [PMID: 21850156].
12. Walker RJ, Anderson NM, Jiang Y, Bahouth S, Steinle JJ. Role of beta-adrenergic receptor regulation of TNF-alpha and insulin signaling in retinal Muller cells. Invest Ophthalmol Vis Sci 2011; 52:9527-33. [PMID: 22110065].
13. Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T. Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol 2008; 35:846-51. [PMID: 18215180].
14. Grohmann M, Foulstone E, Welsh G, Holly J, Shield J, Crowne E, Stewart C. Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha. J Physiol 2005; 568:229-42. [PMID: 16081485].
15. Clemmons D, Maile L, Xi G, Shen X, Radhakrishnan Y. Igf-I signaling in response to hyperglycemia and the development of diabetic complications. Curr Diabetes Rev 2011; 7:235-45. [PMID: 21707534].
16. Devi TS, Singh LP, Hosoya K, Terasaki T. GSK-3β/CREB axis mediates IGF-1-induced ECM/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: Implications for diabetic retinopathy. Biochim Biophys Acta 2011; xxx:1080-8.
17. Haurigot V, Villacampa P, Ribera A, Llombart C, Bosch A, Nacher V, Ramos D, Ayuso E, Segovia JC, Bueren JA, Ruberte J, Bosch F. Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem 2009; 284:22961-9. [PMID: 19473988].
18. Yamada PM, Lee KW. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 2009; 296:C954-76. [PMID: 19279229].
19. Chang KH, Chan-Ling T, McFarland EL, Afzal A, Pan H, Baxter LC, Shaw LC, Caballero S, Sengupta N, Li Calzi S, Sullivan SM, Grant MB. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA 2007; 104:10595-600. [PMID: 17567755].
20. Kielczewski JL, Hu P, Shaw LC, Li Calzi S, Mames RN, Gardiner TA, McFarland E, Chan-Ling T, Grant MB. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury. Am J Pathol 2011; 178:1517-28. [PMID: 21435441].
21. Liu LQ, Sposato M, Liu HY, Vaudrain T, Shi MJ, Rider K, Stevens Z, Visser J, Deng HK, Kraus M. Functional cloning of IGFBP-3 from human microvascular endothelial cells reveals its novel role in promoting proliferation of primitive CD34+CD38-hematopoietic cells in vitro. Oncol Res 2003; 13:359-71. [PMID: 12725526].
22. Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, Liu L, Soderland C, Kern TS, Ferry R Jr, He H, Yates CR, Miller D, Steinle JJ. Compound 49b Prevent Diabetes-Induced Apoptosis Through Increased IGFBP-3 levels. Invest Ophthalmol Vis Sci 2012;.
23. Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 2002; 160:501-9. [PMID: 11839570].
24. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147:642-53. [PMID: 7545873].
25. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002; 86:363-5. [PMID: 11914197].
26. Lu M, Adamis AP. Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin North Am 2002; 15:69-79. [PMID: 12064083].
27. Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol 2012; 2012:279037-[PMID: 22132315].
28. Gustavsson C, Agardh CD, Zetterqvist AV, Nilsson J, Agardh E, Gomez MF. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS ONE 2010; 5:e12699-[PMID: 20856927].
29. Gibson TLB, Cohen P. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm IGF Res 1999; 9:241-53. [PMID: 10512690].
30. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115:1111-9. [PMID: 15864338].
31. Yasuoka H, Zhou Z, Pilewski JM, Oury TD, Choi AM, Feghali-Bostwick CA. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am J Pathol 2006; 169:1633-42. [PMID: 17071587].
32. Wagers AJ, Waters CM, Stoolman LM, Kansas GS. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on alpha1, 3-fucosyltransferase VII gene expression. J Exp Med 1998; 188:2225-31. [PMID: 9858509].
33. Lawrence MB, McIntire LV, Eskin SG. Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion. Blood 1987; 70:1284-90. [PMID: 3663936].
34. Walker RJ, Steinle JJ. Role of beta-adrenergic receptors in inflammatory marker expression in Muller cells. Invest Ophthalmol Vis Sci 2007; 48:5276-81. [PMID: 17962483].
35. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008; 214:149-60. [PMID: 18161752].
36. Shi JX, Su X, Xu J, Zhang WY, Shi Y. MK2 posttranscriptionally regulates TNF-alpha-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2012; 302:L793-9. [PMID: 22268119].
37. Sanadgol N, Mostafaie A, Bahrami G, Mansouri K, Ghanbari F, Bidmeshkipour A. Elaidic acid sustains LPS and TNF-alpha induced ICAM-1 and VCAM-I expression on human bone marrow endothelial cells (HBMEC). Clin Biochem 2010; 43:968-72. [PMID: 20451511].
38. Gribben L, Baxter RC, Marsh DJ. Insulin-like growth factor binding protein-3 inhibits migration of endometrial cancer cells. Cancer Lett 2012; 317:41-8. [PMID: 22085490].
39. Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem 2010; 285:30233-46. [PMID: 20353938].
40. Massoner P, Colleselli D, Matscheski A, Pircher H, Geley S, Jansen Durr P, Klocker H. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility. Endocr Relat Cancer 2009; 16:795-808. [PMID: 19509068].
41. Han J, Jogie-Brahim S, Harada A, Oh Y. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-kappaB signaling. Cancer Lett 2011; 307:200-10. [PMID: 21536375].
42. Williams AC, Smartt H. AM HZ, Macfarlane M, Paraskeva C, Collard TJ Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ 2007; 14:137-45. [PMID: 16645643].